Ironsides Asset Advisors’s Immunomedics Inc IMMU Stock Holding History

Ironsides Asset Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,366	Closed	-$1.99M	–	89
2020 Q3	$1.99M	Sell	23,366 -2,539	-10%	-$128K	0.63%	20
2020 Q2	$918K	Buy	25,905 +50	+0.2%	+$1.46K	0.3%	39
2020 Q1	$349K	Sell	25,855 -17,115	-40%	-$288K	0.21%	51
2019 Q4	$909K	Sell	42,970 -2,075	-5%	-$36.6K	0.28%	46
2019 Q3	$597K	Buy	45,045 +11,715	+35%	+$172K	0.2%	51
2019 Q2	$462K	Hold	33,330	–	–	0.16%	59
2019 Q1	$640K	Buy	33,330 +10,300	+45%	+$166K	0.21%	47
2018 Q4	$329K	Buy	+23,030	New	+$457K	0.12%	69

Ironsides Asset Advisors's IMMU Position: Q4 2020 in Review

Ironsides Asset Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 23,366 shares — an estimated $1.99M sold.

Ironsides Asset Advisors first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $1.99M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Ironsides Asset Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Ironsides Asset Advisors sold 23,366 Immunomedics Inc shares in Q4 2020, an estimated $1.99M.
Ironsides Asset Advisors first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
Ironsides Asset Advisors's Immunomedics Inc position peaked at $1.99M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Ironsides Asset Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.